Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|August 1, 2018
Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell LineGenyuan Zhu, Satoshi Nemoto, Adam W Mailloux, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Hypoxic stress granules trigger immunogenic dormancy in lung cancerMatthew G Smith, Alexis Rebecca Ramos, Heena Panchal, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndromeAdam W Mailloux, Chiharu Sugimori, Rami S Komrokji, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2013
Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemiaAdam W Mailloux, Ling Zhang, Lynn Moscinski, et al.Clinical Lymphoma, Myeloma & Leukemia|February 5, 2019
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic SyndromesRami S Komrokji, Sheng Wei, Adam W Mailloux, et al.Haematologica|February 4, 2014
A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response predictionRami S Komrokji, Adam W Mailloux, Dung-Tsa Chen, et al.Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.Blood|June 14, 2012
Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in miceCrystina L Kriss, Javier A Pinilla-Ibarz, Adam W Mailloux, et al.Frontiers in Immunology|March 13, 2020
Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving ImmunotherapySaurabh K Garg, Matthew J Ott, A G M Mostofa, et al.JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.Pageof 3